The Revitalize-1 Study is evaluating a new treatment for adults with type 2 diabetes that may eliminate or reduce insulin requirements.
You may qualify if you:
Are 21–70 years of age
Have been diagnosed with type 2 diabetes
Are currently taking insulin
Find out if you might be prequalified to participate in this study by completing the quick survey below.
We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
For more detailed information on the cookies we use, please check our Privacy Policy.
By continuing to access this website you are giving us consent to collect cookies.
